[Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19.

RCT: Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19 – Together Clinical Trials

Related:

Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine).

Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19

Commentary on Twitter

@TogetherTrial Manuscript Pre-print regarding #Fluvoxamine for early #COVID19 is online athttps://t.co/teHqMlowld
demonstrating ~30% relative reduction in ER visits / hospitalizations with fluvoxamine 100mg 2x/day in a 10-site, double-blind randomized trial. #IDtwitter pic.twitter.com/727by0lqft

— David Boulware, MD MPH (@boulware_dr) August 23, 2021